These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36267001)

  • 41. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing blood biomarkers to clinical decision rules to select patients suspected of traumatic brain injury for head computed tomography.
    Li Y; Ding VY; Chen H; Zhu G; Jiang B; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    Neuroradiol J; 2023 Feb; 36(1):68-75. PubMed ID: 35588232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
    Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
    J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of Early Diagnostic Value of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase Blood Levels in Minor Head Trauma in Turkey.
    Polat ZM; Yucel M; Cikriklar HI; Altındiş M; Yurumez Y
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients.
    Ward MD; Weber A; Merrill VD; Welch RD; Bazarian JJ; Christenson RH
    J Appl Lab Med; 2020 Jan; 5(1):91-100. PubMed ID: 32445344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interest of blood biomarkers to predict lesions in medical imaging in the context of mild traumatic brain injury.
    Bouvier D; Oris C; Brailova M; Durif J; Sapin V
    Clin Biochem; 2020 Nov; 85():5-11. PubMed ID: 32781055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-Dependent Differences in Blood Levels of Glial Fibrillary Acidic Protein but Not Ubiquitin Carboxy-Terminal Hydrolase L1 in Children.
    Mannix R; Borglund E; Monashefsky A; Master C; Corwin D; Badawy M; Thomas DG; Reisner A
    Neurology; 2024 Aug; 103(3):e209651. PubMed ID: 38986044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood biomarkers of mild traumatic brain injury: State of art.
    Sapin V; Gaulmin R; Aubin R; Walrand S; Coste A; Abbot M
    Neurochirurgie; 2021 May; 67(3):249-254. PubMed ID: 33482234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
    Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
    Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?
    Rhine T; Babcock L; Zhang N; Leach J; Wade SL
    Brain Inj; 2016; 30(10):1231-8. PubMed ID: 27416022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.
    Kocik VI; Dengler BA; Rizzo JA; Ma Moran M; Willis AM; April MD; Schauer SG
    Mil Med; 2024 May; 189(5-6):e1374-e1380. PubMed ID: 37995274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis.
    Mondello S; Sorinola A; Czeiter E; Vámos Z; Amrein K; Synnot A; Donoghue E; Sándor J; Wang KKW; Diaz-Arrastia R; Steyerberg EW; Menon DK; Maas AIR; Buki A
    J Neurotrauma; 2021 Apr; 38(8):1086-1106. PubMed ID: 29020853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study.
    Kou Z; Gattu R; Kobeissy F; Welch RD; O'Neil BJ; Woodard JL; Ayaz SI; Kulek A; Kas-Shamoun R; Mika V; Zuk C; Tomasello F; Mondello S
    PLoS One; 2013; 8(11):e80296. PubMed ID: 24260364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability of Blood Biomarkers of Traumatic Brain Injury.
    Rezaii PG; Grant GA; Zeineh MM; Richardson KJ; Coburn ML; Bet AM; Weber A; Jiang B; Li Y; Ubungen K; Routh G; Wheatcroft AM; Paulino AD; Hayes RL; Steinberg GK; Wintermark M
    J Neurotrauma; 2019 Aug; 36(16):2407-2416. PubMed ID: 30968744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early GFAP and UCH-L1 point-of-care biomarker measurements for the prediction of traumatic brain injury and progression in patients with polytrauma and hemorrhagic shock.
    Sperry JL; Luther JF; Okonkwo DO; Vincent LE; Agarwal V; Cotton BA; Cannon JW; Schreiber MA; Moore EE; Namias N; Minei JP; Urbanek KL; Yazer MH; Puccio AM; Fox EE; Brown JB; Neal MD; Guyette FX; Wisniewski SR; ; ;
    J Neurosurg; 2024 May; ():1-10. PubMed ID: 39076152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.